Delivery Order SPE2DB20D3101-SPE2DB25FQYG7

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order valued at $1,675.48 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The order has a firm fixed price and is set to be completed by November 20, 2024. AmerisourceBergen Drug Corp, a for-profit organization, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $7,100.48 firm-fixed-price contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The contract has a completion date of July 29, 2024 and was awarded on July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract has a ceiling value of $9,989.06 and is a firm fixed price delivery order with a completion date of May 23, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been a significant supplier of medical commodities to various...
This is a firm fixed price delivery order for $1,020.00 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,782.68 firm-fixed-price delivery order is for the provision of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with a completion date of February 28, 2024 and a potential value of $2,142.00. The contract does not have a set-aside...
This federal contract award is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,819.84, is for the supply of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 300ML. The award has a firm fixed price and is not designated with any set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,042.18 firm fixed-price delivery order is for the supply of the drug "KONVOMEP 2-84 MG/ML ORAL SUSP 90ML", which is likely a pharmaceutical product used in federal healthcare programs. The contract has an ultimate completion date of December 10, 2024 and was awarded on December 9,...
This award is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,794.95 with a firm fixed price. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a pharmaceutical product. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $4,284.38 firm fixed price delivery order is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract has a completion date of January 17, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FQYG7
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,975.26, is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 7, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/7/25, 10:47 AM